Product news

Share this article:
FDA has approved an NDA for LoSeasonique, an oral contraceptive manufactured by Duramed, a subsidiary of Barr Pharmaceuticals.
 
Eli Lilly & Co. has announced the introduction of a color differentiation system for U-100 insulin products marketed in the US, including vials, pens and individual packaging for Humalog and Humulin

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions